- The report contains detailed information about Genomma Lab Internacional SAB de CV that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Genomma Lab Internacional SAB de CV. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Genomma Lab Internacional SAB de CV financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Genomma Lab Internacional SAB de CV competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Genomma Lab Internacional SAB de CV business.
About Genomma Lab Internacional SAB de CV
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, develops, sells, and markets various over-the-counter pharmaceutical and personal care products in Mexico and Latin America. It offers approximately 90 products in various categories, including anti-acne, sexual protection and enhancement, anti-wrinkle, scar removal ointments, hemorrhoid treatments, anti-acids, anti-ulcer, varicose vein treatments, osteoarthritis, analgesics, cold remedies, anti-fungal, anti-inflammatory, expectorants and multivitamins, and wart removal treatments. The companys products include Asepxia, a line of medication and dermocosmetic products to care for skin prone to acne; Ultra Bengue, which provides anti-inflammatory relief; Cicatricure for scars, lines, and wrinkles; Dalay, which is used to treat nervous tension, irritability, and sleeplessness; ExCelsus, a sugar free vitamin C gum tablet; GargaX for reducing inflammation, irritation, and throat aches provoked by infectious processes; Genoprazol for gastritis; and Goicoechea and Goicoechea Diabet TX, body moisturizing lotions. Its products also comprise Goicotabs, a medication to treat the symptoms of chronic and peripheral venous insufficiency; Nikzon to treat and relieve pain, inflammation, and the burning sensation caused by hemorrhoids; Pointts, a wart and mole elimination system; Resphry to treat sneezing, nose runs, and tears; Silka Medic, a gel for athletes; Shot-B, vitamin tablets; and X ray tablets to treat osteoarthritis. In addition, the company offers QG5 for the treatment of colitis; Ma Evans Hair Color, a shampoo product for men; and Asepxia Liquid Makeup products. It offers its products through self-service stores, drugstores, restaurants, and department stores. Genomma Lab Internacional has a strategic alliance with Grupo Televisa SA. The company was formerly known as Producciones Infovision, S.A. de C.V. Genomma Lab Internacional was founded in 1996 and is based in Mexico City, Mexico.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. GENOMMA LAB INTERNACIONAL SAB DE CV COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. GENOMMA LAB INTERNACIONAL SAB DE CV BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. GENOMMA LAB INTERNACIONAL SAB DE CV SWOT ANALYSIS
4. GENOMMA LAB INTERNACIONAL SAB DE CV FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. GENOMMA LAB INTERNACIONAL SAB DE CV COMPETITORS AND INDUSTRY ANALYSIS
5.1. Genomma Lab Internacional SAB de CV Direct Competitors
5.2. Comparison of Genomma Lab Internacional SAB de CV and Direct Competitors Financial Ratios
5.3. Comparison of Genomma Lab Internacional SAB de CV and Direct Competitors Stock Charts
5.4. Genomma Lab Internacional SAB de CV Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Genomma Lab Internacional SAB de CV Industry Position Analysis
6. GENOMMA LAB INTERNACIONAL SAB DE CV NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. GENOMMA LAB INTERNACIONAL SAB DE CV EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. GENOMMA LAB INTERNACIONAL SAB DE CV ENHANCED SWOT ANALYSIS2
9. MEXICO PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. GENOMMA LAB INTERNACIONAL SAB DE CV IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. GENOMMA LAB INTERNACIONAL SAB DE CV PORTER FIVE FORCES ANALYSIS2
12. GENOMMA LAB INTERNACIONAL SAB DE CV VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Genomma Lab Internacional SAB de CV Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Genomma Lab Internacional SAB de CV Key Executives
Key Executives Biographies1
Key Executives Compensations1
Genomma Lab Internacional SAB de CV Major Shareholders
Genomma Lab Internacional SAB de CV History
Genomma Lab Internacional SAB de CV Products
Revenues by Segment
Revenues by Region
Genomma Lab Internacional SAB de CV Offices and Representations
Genomma Lab Internacional SAB de CV SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Genomma Lab Internacional SAB de CV Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Genomma Lab Internacional SAB de CV Capital Market Snapshot
Genomma Lab Internacional SAB de CV Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Genomma Lab Internacional SAB de CV Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Genomma Lab Internacional SAB de CV Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Genomma Lab Internacional SAB de CV Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Genomma Lab Internacional SAB de CV 1-year Stock Charts
Genomma Lab Internacional SAB de CV 5-year Stock Charts
Genomma Lab Internacional SAB de CV vs. Main Indexes 1-year Stock Chart
Genomma Lab Internacional SAB de CV vs. Direct Competitors 1-year Stock Charts
Genomma Lab Internacional SAB de CV Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?